MENU

AORT Stock Artivion (AORT, $40.95) soared +41.65% and reached a 3-month high. Expect an Uptrend reversal

A.I.dvisor
at Tickeron.com
Loading...
AORT - Artivion
3-month jump
Bearish Trend
Odds of DOWN Trend
Tickeron

Loading...

Price: $40.95
Daily change: +$8.25 (+25.23%)
Daily volume: 1.7M
3-month price change: +$12.04 (+41.65%)
Capitalization: $1.9B
Industry: Medical/Nursing Services
Artivion (AORT, $40.95) gained +4 and reached a new high over the last three months. By comparison, the broader Medical/Nursing Services Industry returned 1 over the same period of time. A.I.dvisor analyzed 229 stocks in the Medical/Nursing Services Industry over the same period of time and found that of them (5) were in an Uptrend while of them (4) showed a Downtrend. A.I.dvisor found 363 similar cases when AORT's price went up within three months. In out of those 363 cases, AORT's price went down during the next month. Based on these historical data, A.I. thinks the odds of an Uptrend reversal for AORT are

AORT's RSI Indicator soars into overbought territory

The RSI Indicator for AORT moved into overbought territory on August 08, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AORT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AORT broke above its upper Bollinger Band on August 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 29, 2025. You may want to consider a long position or call options on AORT as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AORT just turned positive on August 05, 2025. Looking at past instances where AORT's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AORT advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 258 cases where AORT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AORT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.602) is normal, around the industry mean (57.379). P/E Ratio (0.000) is within average values for comparable stocks, (37.765). AORT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.644). AORT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (4.320) is also within normal values, averaging (90.474).

View a ticker or compare two or three
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AORT showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of cryopreserved human tissue for vascular transplant applications

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1655 Roberts Boulevard North West
Phone
+1 770 419-3355
Employees
1500
Web
https://www.artivion.com